Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Obesity, Overweight, or Chronic Weight Management”

12 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 12 of 12 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06858839
What this trial is testing

Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

Who this might be right for
Obesity
Amgen 3,853
Testing effectiveness (Phase 2)Looking for participantsNCT06143956
What this trial is testing

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Who this might be right for
ObesityOverweight
Eli Lilly and Company 1,481
Large-scale testing (Phase 3)Active Not RecruitingNCT06858878
What this trial is testing

Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2 Diabetes Mellitus Who Have Obesity or Are Overweight

Who this might be right for
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Amgen 1,105
Testing effectiveness (Phase 2)Study completedNCT06230523
What this trial is testing

LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight

Who this might be right for
ObesityOverweight and Obesity
Eli Lilly and Company 263
Testing effectiveness (Phase 2)Study completedNCT06703021
What this trial is testing

A Dose-Range Study of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

Who this might be right for
ObesityOverweightChronic Weight Management
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics 85
Not applicableLooking for participantsNCT04824248
What this trial is testing

Weight Reduction in CLBP

Who this might be right for
Chronic Low-back PainOverweight or Obesity
Vrije Universiteit Brussel 84
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07553299
What this trial is testing

Weekly Oral Dose of Ecnoglutide (VRB-101) for Weight Maintenance in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities

Who this might be right for
ObesityOverweightWeight Maintenance
Verdiva Bio Dev Limited 120
Not applicableStudy completedNCT00510341
What this trial is testing

Evaluating the Collaborative Management in Pediatrics (CMP) Training Program Among Pediatric Resident Doctors and Their Patients With Asthma or Obesity

Who this might be right for
EducationAsthmaObesity
University of Washington 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT07169942
What this trial is testing

Aleniglipron Phase 2 Body Composition Study

Who this might be right for
Obesity, Overweight, or Chronic Weight Management
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics 71
Testing effectiveness (Phase 2)Study completedNCT07002905
What this trial is testing

Evaluate the Efficacy, Safety, and Tolerability in Participants With Obesity or Overweight With Weight-Related Comorbidities

Who this might be right for
Chronic Weight Management
Ascletis Pharma (China) Co., Limited 125
Testing effectiveness (Phase 2)Active Not RecruitingNCT06693843
What this trial is testing

A Phase 2b, Dose-range Finding Study of the Efficacy and Safety of Multiple Doses of Aleniglipron (GSBR-1290) in Participants Living With Obesity or Overweight With at Least One Weight-related Comorbidity

Who this might be right for
Obesity, Overweight, or Chronic Weight Management
Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics 220
Large-scale testing (Phase 3)Looking for participantsNCT06672549
What this trial is testing

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Who this might be right for
ObesityOverweight
Eli Lilly and Company 125